MedPath

ELBA TRIAL.Vena basilica transpositie versus elleboogsfistel voor hemodialyse.

Recruiting
Conditions
hemodialysis, end stage renal disease (ESRD), fistula, patency, steal, thrombosisdialyse, nierfalen, av-fistel,
Registration Number
NL-OMON25309
Lead Sponsor
Dr AC vd Ham, vascular surgeon Sint Franciscus Gasthuis RotterdamDr JHM Tordoir, vascular surgeon Ac ziekenhuis MaastrichtDr AAEAde Smet, vascular surgeon Maastadziekenhuis RotterdamDr MPFM Vrancken Peeters, vascular surgeon Erasmus Medisch Centrum Rotterdam
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
215
Inclusion Criteria

1. Failing fore-arm fistula;

2. No options for fore-arm fistula ( venous and arterial diameter < 2 mm );

Exclusion Criteria

1. Locoregional or systemic infection;

2. Not being able to give informed consent;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Is there a difference in primary patency after one year in vena basilica transposition compared with brachiocubiti fistula for chronic hemodialysis.
Secondary Outcome Measures
NameTimeMethod
1. Is there a difference in thrombosis-free interval;<br /><br>2. Is there a difference in the amount of interventions needed;<br /><br>3. Is there a difference in usability,<br>related to: duration untill first cannulation, total time of non-usability as a result of revision operations, easy cannulation, hemostasis after cannulation, hematoma, infection, steal, aneurysm, oedema;<br /><br>4. Effect of the fistula on peripheral circulation.
© Copyright 2025. All Rights Reserved by MedPath